PLoS ONE (Apr 2008)

BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family history.

  • Gaik Theng Toh,
  • Peter Kang,
  • Sharlene S W Lee,
  • Daphne Shin-Chi Lee,
  • Sheau Yee Lee,
  • Suhaida Selamat,
  • Nur Aishah Mohd Taib,
  • Sook-Yee Yoon,
  • Cheng Har Yip,
  • Soo-Hwang Teo

DOI
https://doi.org/10.1371/journal.pone.0002024
Journal volume & issue
Vol. 3, no. 4
p. e2024

Abstract

Read online

BackgroundIn Asia, breast cancer is characterised by an early age of onset: In Malaysia, approximately 50% of cases occur in women under the age of 50 years. A proportion of these cases may be attributable, at least in part, to genetic components, but to date, the contribution of genetic components to breast cancer in many of Malaysia's ethnic groups has not been well-characterised.MethodologyGiven that hereditary breast carcinoma is primarily due to germline mutations in one of two breast cancer susceptibility genes, BRCA1 and BRCA2, we have characterised the spectrum of BRCA mutations in a cohort of 37 individuals with early-onset disease (ConclusionsHere, we report a total of 14 BRCA1 and 17 BRCA2 sequence alterations, of which eight are novel (3 BRCA1 and 5 BRCA2). One deleterious BRCA1 mutation and 2 deleterious BRCA2 mutations, all of which are novel mutations, were identified in 3 of 37 individuals. This represents a prevalence of 2.7% and 5.4% respectively, which is consistent with other studies in other Asian ethnic groups (4-9%).